關於 biosimilar drugs ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. What's the difference? Biosimilar and generic drugs?

Synthetic branded drugs can be exactly replicated into more affordable generic versions, but because biologics involve large, complex molecules, ...

#12. Biosimilar Drugs - BC Cancer

The active ingredients in generic drugs are exactly the same (identical) as the brand name drug, while biosimilars are highly similar but not exact copies. The ...

#13. Biosimilars – What You Need to Know - Cancer Care Ontario

What are biologics and biosimilar drugs? · Biologics are medications that are made from living cells, like animal cells, bacteria or yeast. · Since biologic drugs ...

#14. Biosimilar medicinal products | Italian Medicines Agency - AIFA

Biosimilar medicines are medicines “similar” in quality, efficacy and safety to the reference biological medicines and are not subject to patent coverage.

#15. Biosimilar Drugs - CADTH

Authorization of a biosimilar by Health Canada means that the biosimilar and the reference biologic drug are highly similar and that there are no clinically.

#16. Biosimilars - Information for Patients - MOH

Biosimilar drugs are proven to be as safe and effective as the alternative higher priced originator biologic drugs and are able to treat many of the same ...

#17. Advantages and efficacy of biosimilar drugs

Biosimilar drugs work the same way as their reference biologic drug. If a patient switches from a biologic drug to a biosimilar drug or starts ...

#18. What are Biosimilars and Biologics?

A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA‐approved biologic product, known as a ...

#19. Biosimilar Medicines - HPRA

In this section of our website, you will find information about biosimilar medicines. A biosimilar is a biological medicine that is highly similar to ...

#20. What Are Biosimilars? Top Facts You May Not Know

A biosimilar is a biological product that is very similar to a reference biologic and for which there are no clinically meaningful differences ...

#21. Biosimilar Drugs, Myths and Reality - Reumatología Clínica

By the time the positive CHMP opinion on Remsima® and Inflectra® was issued, there were 13 more biosimilar medicines approved by the European Commission. None ...

#22. Biosimilars | Biopharmaceuticals | Boehringer Ingelheim US

What are Biosimilars? A biosimilar is a version of a biologic medication that is made by a different company than the one that invented it, with no clinically ...

#23. Explaining Biosimilar Medicines | RPS

Is it possible to switch between an originator biologic and a biosimilar? How will a biosimilar be prescribed? How are adverse drug reactions to biosimilars ...

#24. Use of Biosimilar Medications in Oncology - ASCO Journals

In the United States, the Food and Drug Administration (FDA) defines a biosimilar product as highly similar but not identical to a previously ...

#25. Biosimilars FAQs - Government of Saskatchewan

Find answers to frequently asked questions about biologic and biosimilar drugs, and eligibility for Saskatchewan Drug Plan coverage.

#26. Biosimilar or Biologic Drugs? - Arthritis Foundation

A biosimilar is a biologic. According to the FDA, biosimilars: Are made with the same types of natural sources. Are given the same way. Provide the same ...

#27. Biosimilar Drugs: Overview and Industry Challenges

Biosimilar drugs (also known as biosimilars, or follow-on biologics) are almost identical versions of a medical product or a drug that are produced by a ...

#28. Biosimilars approved in Europe

Product name Active substance Authorization date Manufacturer/ Compan... Abasaglar (previously Abasria) insulin glargine 9 Sep 2014 Eli Lilly/Boehringer Ing... Abseamed epoetin alfa 27 Aug 2007 Medice Arzneimittel Pü... Accofil filgrastim 17 Sep 2014 Accord Healthcare

#29. Biosimilars Initiative - Government of New Brunswick

A biosimilar drug, or biosimilar, is a biologic drug that is very similar to but less expensive than its originator biologic drug. There are no expected ...

#30. 20 Common Biosimilar Drugs in the U.S. - GoodRx

Biosimilar drugs are a growing subset of biologics being developed as a way to access the medications you need at a lower cost.

#31. 2022 U.S. Generic and Biosimilar Medicines Savings Report

Featuring data from IQVIA, the 2022 U.S. Generic and Biosimilar Medicines Savings Report reveals generic and biosimilar drugs generated a record $373 ...

#32. Supporting your patients switching to a biosimilar

What is a biosimilar? Biosimilars are highly similar, safe and effective versions of the originator biologic drug, but are much less expensive. Why are we ...

#33. Ontario Expanding Safe Use of Biosimilars

Starting March 31, 2023, Ontario Drug Benefit (ODB) recipients who are on an originator biologic will begin to transition to a Health Canada ...

#34. Frequently Asked Questions About Biologic and Biosimilar ...

Answer: A biosimilar is a biologic product developed to be highly similar to a previously FDA approved biologic, known as the reference product. A biosimilar ...

#35. Biosimilar Drugs & Products - McKesson

Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from existing, FDA-approved reference biologics.

#36. Biosimilar Drugs Could Generate $38.4 Billion in Savings over ...

Biologics are complex drugs manufactured in living systems and include insulin, monoclonal antibodies to block inflammation in rheumatoid ...

#37. Biosimilars: What You Should Know

Given the complexity of drug design, biosimilars cannot be exact copies of biologic therapies, but still contain the same active ingredient, mechanism of action ...

#38. Biosimilar medicines | Health Navigator NZ

A biosimilar medicine is a highly similar version of a reference biological medicine, which is the first brand to market. Biological medicines ...

#39. New Resource: How Boosting Biosimilar Medications Can ...

A new AHIP resource highlights how biosimilars offer an effective, lower-cost alternative to a brand name biologic product. In the last 10 years ...

#40. About medicines | Australian Government Department of ...

Biosimilar medicines are highly similar versions of the original, or 'reference', brand of a biological medicine. They are subject to the same ...

#41. Information for Patients about the Nova Scotia Biosimilar ...

Biosimilars are very similar, less expensive versions of original biologic medications. Biosimilars aren't an exact copy of the original biologic medication, ...

#42. Biosimilar Drugs - STAT News

Biosimilars are cheaper versions of biologic drugs. They are approved by the FDA and can be used to treat a variety of diseases, including cancer and ...

#43. Generic and Biosimilar - Medications - National MS Society

The technical term for an equivalent medication for a biologic is biosimilar or follow-on biologic. Many of the medications currently used to manage the MS ...

#44. Biosimilars for Psoriasis

Biosimilar medicines are a type of biologic drug, and may be administered via injections or intravenous infusion. Although biosimilars are ...

#45. Biosimilars Initiative for patients - Province of British Columbia

The Biosimilars Initiative was launched in 2019 to expand health care services in B.C. by switching patients from originator biologic drugs to ...

#46. Biosimilars - Drug Office

The biosimilar product is the copy version of an innovated biological drug. The innovator makes research effort starting from scratch. It has to identify all ...

#47. What are Biologic and Biosimilar Drugs? - YouTube

A biosimilar is a type of biologic medication. Biologics are medicines made from living organisms that have had a major impact on the ...

#48. Switching from Biologic to Biosimilar Drugs

By April 2022, biologic drugs will gradually be replaced with biosimilar drugs. If you are using a biologic drug, you can check with the healthcare professional ...

#49. Biosimilars - Biogen

Biosimilars are medicines that are highly similar 13 to currently available biologic therapies, known as “reference medicines”. Yet biosimilars are unique — they ...

#50. Part B Biosimilar Biological Product Payment - CMS

In accordance with these provisions, the ASP Drug Pricing File reflects the temporary increased amount for qualifying biosimilar biological ...

#51. Biosimilar Drugs to Humira Arriving: Why Prices Won't Be Lower

“Biosimilars are approved by the FDA by demonstrating that they are 'highly similar' to the reference product. That means that they are close ...

#52. Biosimilar prescription drugs prioritized for coverage in NWT

A biosimilar drug is one that is designed to have active properties similar to those of a drug that has previously been licensed. Biosimilar drugs have ...

#53. Adalimumab (Humira) and biosimilars - NHS

NHS medicines information on adalimumab – what it's used for, side effects, dosage and who can take it.

#54. U.S. Public Policies Impacting Biosimilar Drugs

The federal regulatory process for introducing biosimilars and interchangeable products can be improved to provide prescription drug companies ...

#55. Biologics and biosimilar drugs | McGraw Hill's AccessScience

Biologic drugs, also known as biologics or biologicals, are produced using living organisms. Various classic biologics, such as the medical human insulin ...

#56. Safety considerations of biosimilars - Australian Prescriber

For this reason, off‑patent biologic drugs produced by alternative manufacturers are referred to as biosimilars or 'similar biological medicinal ...

#57. Delivering on the Potential of Biosimilar Medicines

By competing with original biologic medicines across a growing range of therapy areas, biosimilars enable stakeholders – including payers, ...

#58. Biologics & Biosimilars - PhRMA

A biosimilar is exactly what its name implies — it is a biologic that is highly similar to and has no clinically meaningful differences from an existing ...

#59. Biosimilar drugs have the potential to save more than USD 54 ...

The drugs, known as biosimilars, could lead to a USD 54 billion reduction in direct spending on biologic drugs from 2018 to 2027, ...

#60. Biosimilar - an overview | ScienceDirect Topics

“Biosimilars” refers to a class of drug called biologicals. Biologicals include antibodies, viruses, vaccines, serums, blood products, and polypeptides (160).

#61. Creating China's Biosimilar Drugs Regulatory System - Frontiers

A biosimilar drug contains active substances similar to the original biologic drug and is similar to the original drug in terms of quality, ...

#62. Biosimilar medicines regulation

A biosimilar medicine - external site is a version of an already registered biological medicine (the reference medicine). These medicines are ...

#63. Biosimilars: 10 Drugs to Watch

Ten innovator drugs have biosimilars that are either being marketed, ... The European Medicines Agency authorizes 11 biosimilar drugs for ...

#64. Biosimilars - Amgen

11 medicines in our portfolio in inflammation and cancer; Invested more than $2 billion across the development of biosimilar medicines; 3 biosimilar ...

#65. Biosimilars: mimicking biological drugs - Nature

Biosimilar drugs are copycat versions of biologics. They are intended to alleviate the financial burdens that are associated with the ...

#66. Comparison of Uptake and Prices of Biosimilars in the US ...

A biosimilar is a biologic agent that is not chemically identical but highly similar to an approved biologic agent (also referred to as a ...

#67. Biological and biosimilar medicinal products

At the same time, we expect that more biosimilar medicines will be developed when patents for the biological medicinal products expire in ...

#68. What are Biologic and Biosimilar Drugs and What is the ...

Biosimilar drugs are chemically and structurally similar to powerful biologic drugs and achieve the same health outcomes, but at a fraction ...

#69. NLPDP Biosimilar Initiative - Health and Community Services

In March 2023, the Newfoundland and Labrador Prescription Drug Program (NLPDP) launched the NLPDP Biosimilars Initiative. Under this initiative, NLPDP ...

#70. Diabetes, Biologic Drugs, and Biosimilar Insulins

Biologic Drugs and Biosimilars. Biologic drugs are made using biotechnology and come from living organisms or from their cells (6–11). They are large and ...

#71. Biologics Are Natural Monopolies (Part 1): Why Biosimilars Do ...

Entering the market after the monopoly period, they are intended to drive down prices through competition. But unlike generic drugs, biosimilars ...

#72. Informing Patients about Biosimilar Medicines: The Role of ...

Biosimilars are biological medicines that contain a version of the active substance of an already authorized biological medicine in the European Economic Area ( ...

#73. Biosimilars Competition Helps Patients More Than Generic ...

This view that competition is not working is particularly true for U.S. biosimilars, which enter the market after patents on a biologic drug ...

#74. Biosimilars explained: 5 questions you've been asking - Optum

A biosimilar is a biological agent that has no clinically meaningful differences from an existing FDA-approved biologic drug also known as a reference ...

#75. Understanding biological and biosimilar medicines – SPS

A biosimilar medicine is a highly similar copy of its reference medicine. Since it is not possible to replicate biological medicines exactly, a ...

#76. Biosimilar drugs may help fight prescription drug costs

While biosimilar drugs are not the same as generic drugs, they're kind of like a generic version of a biologic. According to the Food and Drug Administration ( ...

#77. Biosimilar Drugs: Impacts on Group Insurance Contracts - AGA

The Quebec Government Drug Insurance Plan will transition to biosimilar drugs. Patients will be required to switch to less expensive medication, ...

#78. What They Are and What's in the Pipeline for Breast Cancer

A biosimilar is a new type of biologic drug. A biologic drug or product is made from living things, such as antibodies or proteins. Herceptin ( ...

#79. Friction in the Path to Use of Biosimilar Drugs - NEJM

Friction in the Path to Use of Biosimilar Drugs Despite passage of the Biologics Price Competition and Innovation Act, there are currently ...

#80. Introduction to Biosimilar Medicines

Please don't make the common mistake and think, “biosimilars are generics of biologics.” Biosimilars aren't generics, because generic drugs are copies of brand-.

#81. Biological and biosimilar medicines - Pharmac

A biosimilar medicine is a very similar version of a biological medicine (the original medicine is usually called the reference medicine). Small ...

#82. What Is the Future of Cost Savings With Biosimilar Drugs?

Biosimilars are considered comparable to already approved "reference" biologics in terms of potency, safety, and efficacy, but they are ...

#83. Biologics & Biosimilars Drugs for Arthritis Treatment

Find all the information you need on Biologics and Biosimilars drugs to treat inflammatory arthritis. Whether you're new to biologics, or exploring a switch ...

#84. The Benefits and Drawbacks of Biosimilars

A biosimilar is an agent that is similar, and will have roughly the same efficacy as and most other characteristics of the original molecule. However, the ...

#85. Government biosimilar initiative - Alberta Blue Cross

Biologics are drugs made in, taken from or partly-made from living cells through a complex manufacturing process. The first version of a biologic drug is called ...

#86. Biosimilar Drugs and Pharmacovigilance - Walsh Medical Media

EMA provided guidance on approval of biosimilars since 2005 and in 2006 EMA approved Omnitrope. (somatropin) as the first biosimilar drug in EU, however it has ...

#87. 3 Ways Pharmacy Benefit Programs Can Prepare ... - Truveris

Biologics and biosimilars are produced from living cells. This method of manufacture distinguishes biosimilars from generic drugs, which are ...

#88. Biosimilar Medicines - Nationwide Children's

Biosimilar medicines are somewhat like the 'generic' version of the brand name biologic medicine. However, because biologics are so complex, ...

#89. The current limitations facing biosimilar products and ...

The European Medicines Agency (EMA) describes a biosimilar as “a biological medicine that is similar to another biological medicine that has ...

#90. Biosimilars - Susan G. Komen

What is a biosimilar drug? A biosimilar is a “generic-like” version of a drug that contains biologics. A generic drug has the exact same active chemical ...

#91. Biosimilar Drugs: Expanding area for pharmacists

A biosimilar, previously known in Canada as a subsequent entry biologic, is a drug demonstrated to be highly similar to a current biologic drug ...

#92. Uptake of biosimilar drugs in Canada: analysis of provincial ...

Use of biosimilars can improve competition and reduce drug costs in Canada, but their use remains very low. Biosimilar infliximab ...

#93. High Cost Drugs (including Biosimilars) | PrescQIPP C.I.C

This includes resources that cover some of the general principles and issues relating to the introduction of biosimilar medicines.

#94. France: Recent updates on biosimilar drugs

A biologic drug is a susbtance produced from or derived from a living cell or organism. Biological drugs include many vaccines, antibodies and growth hormones.

#95. Biosimilar products - GOV.UK

A similar biological medicinal product (biosimilar) is a new biological product that has been developed to be similar to an existing biological ...

#96. Biosimilars: the future of prescribing biological medicines

A biosimilar is a comparable version of a biological medicine (the innovator) that already has regulatory approval, i.e. the reference medicine ...

#97. Ministry of Food and Drug Safety

Biosimilar. What is a Biosmilar product? Biological products are usually recombinant protein molecules manufactured in living organisms by ...

#98. Biosimilars - Leukemia & Lymphoma Society

For instance, generic drugs are chemical copies; they use the same active ingredients as brand-name medicines and work the same way. Biosimilars are more ...